FDA Science Board Meeting
October 25, 2002
5630 Fishers Lane, Room 1066
8:00 a.m. – 4:30 p.m.
8:00 a.m.
Call to Order
Robert S. Langer, Sc.D., Science Board
Chair
Introductory Remarks
Lester Crawford, D.V.M.,
Ph.D., Deputy Commissioner, FDA
Introductory Remarks
Norris E. Alderson, Ph.D.,
Senior Associate Commissioner for Science & Health
8:30
a.m. Counter
Terrorism Initiatives at FDA
Andrea Meyerhoff, M.D.,
Director, Counter Terrorism Programs, Office of the
Commissioner
Food
Safety - Counter Terrorism Initiatives
Joseph Levitt, Esq., Director, Center
for Food Safety & Applied Nutrition
(CFSAN)
9:30 a.m.
Discussion
Science Board Members
10:00 a.m.
Break
10:15
Office of Cellular, Tissue, and Gene Therapies (OCTGT)
Kathryn Zoon, Ph.D., Director, Center for Biologics Evaluation &
Research
(CBER)
Philip Noguchi, M.D., Director, OCTGT
11:00
a.m. Discussion
Science Board
11:30 a.m.
Update on Management Oversight of Products
Murray Lumpkin, M.D., Senior
Associate Commissioner
12:00 p.m.
Break for Lunch
1:00 p.m.
Open Public Comment
2:00
p.m.
Pregnancy Labeling/Research & Study Design on Medications Used by
Pregnant Women
Susan Wood, Ph.D., Director,
Office of Women’s Health (OWH), Office of the Commissioner
Margaret Miller, Ph.D., Manager Science Programs, OWH
Kathleen
Uhl, Ph.D., Medical Officer, Pregnancy Labeling Team, CDER
3:00 p.m.
Discussion
Science Board Members
3:30
Pharmaceutical cGMPs Initiative (Update)
Janet Woodcock, M.D., Director, Center for Drug Evaluation &
Research
(CDER)
4:15 p.m.
Discussion
Science Board Members
4:30 p.m.
Science Board Closing Remarks/Future Direction